9 completed, 3 terminated, 2 unknown. 14 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Completed 9, Terminated 3, Unknown 2 |
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Eptifibatide: new trials by email Literature Review of Eptifibatide trials Research Report on Eptifibatide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic Thrombolytic Agent - Acute Ischemic Stroke | Phase 1 / Phase 2 | Unknown | Baylor College of Medicine | 30 | 2022-02-18 | 2022-06-10 |
| Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel Ticagrelor, Eptifibatide, Clopidogrel - Acute Coronary Syndrome, Angina, Unstable | Phase 2 | Completed | University of Alabama at Birmingham | 100 | 2016-11-01 | 2020-05-04 |
| Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion Ticagrelor, Eptifibatide - Acute Coronary Syndrome | Phase 2 | Completed | University of Alabama at Birmingham | 70 | 2014-02-01 | 2017-02-28 |
| Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR) Eptifibatide - Stroke, Brain Infarction | Phase 2 | Completed | Arthur Pancioli | 27 | 2013-09-01 | 2016-01-21 |
| Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis Ilomedin and Integrilin, low molecular weight heparin. - Pneumonia | Phase 2 | Terminated | Thrombologic ApS | 5 | 2012-06-01 | 2016-04-22 |
| Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention Short Tirofiban, Eptifibatide, Long Tirofiban - Myocardial Infarction, Acute Coronary Syndromes | Phase 2 | Completed | Medicure | 535 | 2012-04-01 | 2021-05-13 |
| Effectiveness of Intracoronary Injection of Eptifibatide in Primary Coronary Intervention in STEMI Patients Eptifibatide - Acute Myocardial Infarction | Phase 2 | Unknown | Assaf-Harofeh Medical Center | 50 | 2009-08-01 | 2009-07-24 |
| Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke Eptifibatide, rt-PA - Ischemic Stroke, Stroke | Phase 2 | Completed | University of Cincinnati | 126 | 2009-07-01 | 2014-04-17 |
| A Safety Study of Eptifibatide in Patients With Sickle Cell Disease Eptifibatide, Placebo - Sickle Cell Disease | Phase 1 / Phase 2 | Terminated | University of North Carolina, Chapel Hill | 13 | 2009-01-01 | 2013-06-27 |
| A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks eptifibatide, normal saline - ST-Elevation Myocardial Infarction | Phase 2 | Terminated | Brigham and Women's Hospital | 31 | 2007-11-01 | 2012-08-27 |
| Aspirin Resistance and Percutaneous Coronary Intervention (PCI) Intravenous Glycoprotein inhibitor + ASA, Clopidogrel, Antiplatelet Therapy (ASA, Clopidogrel) - Stable Angina | Phase 2 | Completed | Icahn School of Medicine at Mount Sinai | 36 | 2007-04-01 | 2018-02-14 |
| Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome Otamixaban (XRP0673), unfractionated heparin, eptifibatide - Coronary Disease | Phase 2 | Completed | Sanofi | 3241 | 2006-06-01 | 2014-12-03 |
| Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial activase, integrilin - Stroke | Phase 1 / Phase 2 | Completed | University of Cincinnati | 94 | 2003-07-01 | 2009-05-08 |
| Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) Aspirin, tinzaparin sodium, eptifibatide - Ischemic Stroke | Phase 2 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 18 | 2003-05-01 | 2013-02-04 |
Ischemic Stroke (4) · Acute Coronary Syndrome (3) · Stroke (3) · Angina, Unstable (2) · Brain Infarction (2) · Thrombosis (2) · Anemia, Sickle Cell (1) · Angina, Stable (1) · Blushing (1) · Coronary Disease (1) · Death (1) · Hemorrhage (1) · Myocardial Infarction (1) · Pneumonia (1) · ST Elevation Myocardial Infarction (1)
University of Alabama at Birmingham (2) · University of Cincinnati (2) · Arthur Pancioli (1) · Assaf-Harofeh Medical Center (1) · Baylor College of Medicine (1) · Brigham and Women's Hospital (1) · Icahn School of Medicine at Mount Sinai (1) · Medicure (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Sanofi (1) · Thrombologic ApS (1) · University of North Carolina, Chapel Hill (1)
United States (12) · Denmark (2) · Finland (2) · Israel (2) · Argentina (1) · Austria (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · Colombia (1) · Croatia (1) · Czechia (1) · Estonia (1) · France (1)
Massoud Leesar, MD (2) · Annapoorna S Kini, MD MRCP (1) · Arthur M Pancioli, MD (1) · Arthur Pancioli, MD (1) · C. Michael Gibson, M.D. (1) · Eugene Braunwald, M.D. (1) · Kenneth I Ataga, MD (1) · Opeolu Adeoye, MD (1) · Opeolu M Adeoye, MD (1) · Steven V Manoukian, MD (1) · Steven Warach, MD, PhD (1)
PMID 19717184, PMID 23887841, PMID 23973010, PMID 26243231, PMID 28611098, PMID 31766977
P50NS044283 (1)